STADA IRBESARTAN HCT 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister Australien - Englisch - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; povidone; hydrogenated castor oil; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle Australien - Englisch - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle

sandoz pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: macrogol 6000; hyprolose; hypromellose; iron oxide yellow; lactose monohydrate; purified talc; titanium dioxide; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; iron oxide red; croscarmellose sodium - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan HCTZ MLabs 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

irbesartan hctz mlabs 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack

micro labs pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: polysorbate 80; sodium starch glycollate type b; colloidal anhydrous silica; mannitol; hypromellose; povidone; magnesium stearate; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AVSARTAN irbesartan 150 mg film-coated tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

avsartan irbesartan 150 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; macrogol 6000; microcrystalline cellulose; sodium starch glycollate type b; hypromellose; magnesium stearate; polysorbate 80 - indicated for the treatment of hypertension.,indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.

APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000; iron oxide black - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN HCT MYLAN 300/25 irbesartan/hydrochlorothiazide 300/25 mg tablet bottle Australien - Englisch - Department of Health (Therapeutic Goods Administration)

irbesartan hct mylan 300/25 irbesartan/hydrochlorothiazide 300/25 mg tablet bottle

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; sodium lauryl sulfate; povidone; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black - abisart hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBEVEL HCTZ 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

irbevel hctz 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack

gm pharma international pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan/Hydrochlorothiazide LAPL 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

irbesartan/hydrochlorothiazide lapl 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

lupin australia pty limited - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; mannitol; magnesium stearate; crospovidone; povidone; poloxamer; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - irbesartan/hctz tablets are indicated for the following:treatment of hypertension.treatment should not be initiated with this fixed-dose combination.

APX-IRBESARTAN HCTZ 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

apx-irbesartan hctz 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: polysorbate 80; iron oxide yellow; sodium starch glycollate type b; colloidal anhydrous silica; iron oxide red; mannitol; povidone; hypromellose; magnesium stearate; titanium dioxide; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

BTC IRBESARTAN HCTZ 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

btc irbesartan hctz 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: povidone; polysorbate 80; iron oxide yellow; magnesium stearate; hypromellose; iron oxide red; sodium starch glycollate type b; mannitol; colloidal anhydrous silica; titanium dioxide; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.